Skip to main content
. 2024 May 1;24:385. doi: 10.1186/s12877-024-05002-4

Table 3.

The association between the TyG index and all cause in-hospital and ICU mortality in patients with ICH from MIMI-IV

Variables Model 1 Model 2 Model 3
OR(95% CI) P value P-trend OR(95% CI) P value P-trend OR(95% CI) P value P-trend
Hospital mortality
 Continuous variable per unit 1.84 (1.37,2.48)  < 0.001 2.11 (1.55,2.90)  < 0.001 1.75 (1.20,2.52) 0.003
 Quantilea  < 0.001  < 0.001 0.017
 Q1 (n = 198) Ref
 Q2 (n = 197) 1.52 (0.81,2.91) 0.197 1.56 (0.82,3.00) 0.177 1.29 (0.65,2.60) 0.463
 Q3 (n = 198) 1.38 (0.73,2.66) 0.329 1.50 (0.79,2.91) 0.222 1.03 (0.51,2.11) 0.934
 Q4 (n = 198) 2.69 (1.51,4.97) 0.001 3.29 (1.80,6.22)  < 0.001 2.31 (1.18,4.67) 0.017
ICU mortality
 Continuous variable per unit 1.96 (1.40,2.72)  < 0.001 2.15 (1.51,3.05)  < 0.001 2.15 (1.45,3.17)  < 0.001
 Quantilea  < 0.001  < 0.001  < 0.001
 Q1 (n = 198) Ref
 Q2 (n = 197) 1.17 (0.54,2.57) 0.685 1.18 (0.54,2.59) 0.679 1.07 (0.47,2.45) 0.872
 Q3 (n = 198) 1.34 (0.63,2.88) 0.449 1.42 (0.67,3.07) 0.366 1.30 (0.59,2.92) 0.524
 Q4 (n = 198) 2.85 (1.48,5.78) 0.002 3.26 (1.66,6.77)  < 0.001 3.24 (1.54,7.11) 0.002

aTyG index: Q1 (7.29–8.38), Q2 (8.38–8.72), Q3 (8.72–9.17), Q4 (9.17–12.08)

Model 1: unadjusted

Model 2: adjusted for age and gender

Model 3: adjusted for age, gender, GCS, hypertension, congestive heart failure, WBC, serum creatinine, serum BUN, serum bilirubin, serum AST, PT, anticoagulant agents, and antiplatelet agents